269 related articles for article (PubMed ID: 19321476)
1. Rituximab for treatment of ocular inflammatory disease: a series of four cases.
Kurz PA; Suhler EB; Choi D; Rosenbaum JT
Br J Ophthalmol; 2009 Apr; 93(4):546-8. PubMed ID: 19321476
[TBL] [Abstract][Full Text] [Related]
2. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature.
Gumus K; Mirza GE; Cavanagh HD; Karakucuk S
Eye Contact Lens; 2009 Sep; 35(5):275-8. PubMed ID: 19687744
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
4. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
[TBL] [Abstract][Full Text] [Related]
5. Six refractory lupus patients treated with rituximab: a case series.
Gillis JZ; Dall'era M; Gross A; Yazdany J; Davis J
Arthritis Rheum; 2007 Apr; 57(3):538-42. PubMed ID: 17394185
[No Abstract] [Full Text] [Related]
6. The use of infliximab in ocular inflammation.
Prendiville C; O'Doherty M; Moriarty P; Cassidy L
Br J Ophthalmol; 2008 Jun; 92(6):823-5. PubMed ID: 18408083
[TBL] [Abstract][Full Text] [Related]
7. Biologic response modifier therapy for psoriatic ocular inflammatory disease.
Huynh N; Cervantes-Castaneda RA; Bhat P; Gallagher MJ; Foster CS
Ocul Immunol Inflamm; 2008; 16(3):89-93. PubMed ID: 18569794
[TBL] [Abstract][Full Text] [Related]
8. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for myasthenia gravis: three case reports and review of the literature.
Stieglbauer K; Topakian R; Schäffer V; Aichner FT
J Neurol Sci; 2009 May; 280(1-2):120-2. PubMed ID: 19272616
[TBL] [Abstract][Full Text] [Related]
10. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
Suhler EB; Lim LL; Beardsley RM; Giles TR; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Smith JR; Rosenbaum JT
Ophthalmology; 2014 Oct; 121(10):1885-91. PubMed ID: 24953794
[TBL] [Abstract][Full Text] [Related]
13. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
Hofstra JM; Deegens JK; Wetzels JF
Nephrol Dial Transplant; 2007 Jul; 22(7):2100-2. PubMed ID: 17389619
[No Abstract] [Full Text] [Related]
14. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
Jacob A; Weinshenker BG; Violich I; McLinskey N; Krupp L; Fox RJ; Wingerchuk DM; Boggild M; Constantinescu CS; Miller A; De Angelis T; Matiello M; Cree BA
Arch Neurol; 2008 Nov; 65(11):1443-8. PubMed ID: 18779415
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
Onal S; Kazokoglu H; Koc A; Yavuz S
Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
[TBL] [Abstract][Full Text] [Related]
17. [Necrotizing scleritis--case report of a patient effectively treated with high doses of corticosteroids].
Chorabik E
Klin Oczna; 1996 Feb; 98(2):133-5. PubMed ID: 9026572
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in refractory pemphigus vulgaris.
Sorce M; Aricò M; Bongiorno MR
Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
[TBL] [Abstract][Full Text] [Related]
19. Rituximab treatment for resistant antiphospholipid syndrome.
Rubenstein E; Arkfeld DG; Metyas S; Shinada S; Ehresmann S; Liebman HA
J Rheumatol; 2006 Feb; 33(2):355-7. PubMed ID: 16465669
[TBL] [Abstract][Full Text] [Related]
20. Rituximab therapy for refractory idiopathic scleritis.
Bogdanic-Werner K; Fernandez-Sanz G; Alejandre Alba N; Ferrer Soldevila P; Romero-Bueno FI; Sanchez-Pernaute O
Ocul Immunol Inflamm; 2013 Aug; 21(4):329-32. PubMed ID: 23662782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
